Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-691-5 | CAS number: 590-86-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
Studies with the main objective to investigate the metabolism of isovaleraldehyde could not be identified. But determinations of plasma levels in rats and humans have been conducted in three studies concerned with investigations related to the disease hepatic encephalopathy. It was demonstrated that isovaleraldehyde is a natural constituent in blood. It originates at least in part from the catabolism of leucine. In rats, colonic bacteria seem to be involved in the formation of isovaleraldehyde while in humans evidence was negative for the participation of colonic bacteria in the formation of isovaleraldehyde.
Kubow 1981
Isovaleraldehyde is naturally present in the plasma of rats and humans at levels of ca. 0.5 to 0.6 mg/L (6 to 7 µmol/L). It is formed at least partly from leucine by gut bacteria (result of a feeding experiment with leucine and neomycin). Further information is not available if there are other sources and if isovaleraldehyde is additionally produced endogenously by mammalian cells/tissues.
Marshall 1985
3-Methylbutanal (isovaleraldehyde) is naturally present in the plasma of healthy human subjects and of patients with chronic liver disease at levels of ca. 0.116 and 0.125 µmol/L respectively. No statistically significant differences in plasma levels were found between control subjects and patients and between fasted and non fasted subjects or patients.
After intake of leucine (9.5 g over 10 min) plasma leucine and 3-methylbutanal levels increased with peak concentration after ca. 100 to 120 min (ca. 3-fold and 10-fold increase respectively). Neomycin had no effect on the results of leucine ingestion.
Mardini 1987
In the blood of healthy control subjects, isovaleraldehyde was present in a mean plasma concentration of 0.17 µmol/L (SEM 0.02). Patient with liver diseases had significantly increased plasma levels (0.58 µmol/L) compared to controls. But within patients, differences were not significant.
Roberts 1991
In an additional study, the deformylation reaction of C3 to C5 aldehydes resulting in olefin formation was investigated using a reconstituted system of different cytochrom P-450 isozymes. This reaction is not a major metabolic pathway of C3 to C5 aldehydes. For isovaleraldehyde, this reaction has no relevance in the in vivo metabolism according to the reaction rate determined (see below).
In order to achieve deformylation and formation of the corresponding olefin, branching at the α-carbon atom was required. Activity increased with increasing branching (trimethylacetaldehyde > 2-methylbutyraldehyde > butyraldehyde). The relative activities of the P-450-isozymes studied are dependent on the substrate tested, varying isozymes being most active with different substrates.
For isovaleraldehyde with branching at the ß-position, the olefinic reaction product could be detected but the reaction rate was very low (below the limit of detection; < 12 pmol of product per min per nmol of P-450).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.